eupatorium
fortunei
ef
long
use
herbal
medicin
korea
china
asian
countri
treat
varieti
diseas
recent
studi
report
ef
antimetastat
antiangiogen
antibacteri
antioxid
activ
well
activ
malign
metastat
human
cancer
effect
ef
compon
virus
report
present
studi
antivir
activ
mechan
action
aqueou
extract
ef
wef
compon
evalu
vitro
found
pretreat
wef
markedli
reduc
viral
replic
evalu
use
green
fluoresc
protein
gfp
tag
viru
influenza
viru
newcastl
diseas
viru
vesicular
stomat
viru
murin
raw
macrophag
cell
demonstr
wef
induc
product
type
ifn
includ
proinflammatori
cytokin
addit
identifi
activ
antivir
compon
wef
quercetin
psoralen
quercitrin
thu
wef
activ
compon
immunomodul
innat
immun
respons
murin
macrophag
find
potenti
use
develop
prophylact
therapeut
treatment
rang
virus
viral
pathogen
caus
malign
diseas
human
anim
result
consider
mortal
morbid
econom
loss
worldwid
thompson
et
al
lindahl
grace
vaccin
treatment
variou
diseas
develop
new
mutant
strain
resist
vaccin
emerg
moscona
rapid
emerg
sever
new
drugresist
virus
necessit
develop
new
treatment
modal
moscona
includ
effect
chemotherapeut
agent
hurt
et
al
choi
et
al
piret
boivin
herbal
medicin
tradit
medicin
use
korea
china
asian
countri
use
thousand
year
combin
variou
compound
method
take
tradit
medicin
typic
involv
oral
administr
water
extract
addit
tradit
medicin
reliev
symptom
variou
diseas
includ
cancer
infecti
diseas
use
thousand
year
still
use
sever
herbal
medicin
use
prevent
treat
viru
infect
immun
enhanc
immun
cha
et
al
current
research
conduct
worldwid
search
antivir
materi
use
tradit
medicin
plant
addit
emerg
toler
exist
antivir
agent
call
develop
new
candid
increas
interest
develop
antivir
agent
use
tradit
medicin
plant
expens
antivir
agent
still
burden
develop
countri
effect
cheap
antivir
agent
one
world
top
prioriti
drug
develop
addit
natur
product
deriv
medicin
plant
play
role
one
import
raw
materi
lead
compound
pharmaceut
therefor
search
antivir
activ
substanc
use
tradit
medicin
plant
offer
great
potenti
develop
potenti
effect
new
antivir
agent
lin
et
al
talactac
et
al
eupatorium
fortunei
ef
long
use
manag
fever
edema
chill
kim
et
al
ef
report
possess
antioxid
antidiabet
antibacteri
activ
antimetastat
antiangiogen
effect
malign
human
cancer
cell
kim
et
al
studi
investig
induct
immunomodulatori
signal
molecul
water
extract
ef
wef
also
sought
identifi
activ
compon
wef
use
uplcmsm
addit
evalu
efficaci
wef
influenza
viru
new
castl
diseas
viru
vesicular
stomat
viru
vitro
wef
prepar
describ
previous
kim
et
al
dri
ef
purchas
yeongcheon
orient
herbal
market
yeongcheon
south
korea
store
kmapplic
center
herbarium
registr
number
korea
institut
orient
medicin
kiom
verif
ident
prof
ki
hwan
bae
chungnam
nation
univers
daejeon
korea
wef
filter
standard
siev
retsch
haan
germani
concentr
lyophil
store
c
use
madindarbi
canin
kidney
mdck
atcc
african
green
monkey
kidney
vero
atcc
murin
macrophag
atcc
cell
cultur
dulbecco
modifi
eagl
medium
dmem
lonza
walkersvil
md
contain
fetal
bovin
serum
fb
cellgro
manassa
va
usa
antibiot
uml
penicillin
streptomycin
c
co
describ
previous
influenza
green
fluoresc
protein
gfp
tag
influenza
ndvgfp
propag
allanto
fluid
chicken
embryo
vsvgfp
propag
confluent
vero
cell
cell
viabil
measur
h
incub
wef
use
mt
assay
promega
madison
wi
usa
accord
supplier
instruct
choi
et
al
briefli
raw
cellswel
cell
seed
tissu
cultur
plate
incub
h
c
co
wef
ad
cell
incub
h
ten
microlit
mt
solut
ad
well
cell
incub
addit
h
absorb
nm
record
use
glomax
explor
system
promega
madison
wi
usa
choi
et
al
viral
replic
inhibit
assay
perform
use
gfp
virus
describ
previous
choi
et
al
test
antivir
effect
wef
viral
pathogen
previous
use
studi
challeng
virus
vsv
ndv
talactac
et
al
cell
cellswel
seed
plate
cell
incub
h
cell
incub
h
dmem
alon
untreat
virusonli
group
dmem
u
recombin
mous
interferon
posit
control
dmem
wef
cell
infect
moi
ndvgfp
moi
vsvgfp
moi
gfp
express
measur
h
postinfect
hpi
magnif
measur
hpi
use
glomax
multidetect
system
promega
wisconsin
usa
per
manufactur
instruct
talactac
et
al
level
murin
bd
bioscienc
usa
bd
bioscienc
usa
pbl
interferon
sourc
usa
cultur
supernat
measur
use
elisa
antibodi
kit
follow
manufactur
instruct
wadsworth
koop
talactac
et
al
total
rna
isol
raw
cell
lysat
use
rneasi
mini
kit
qiagen
hilden
germani
follow
manufactur
instruct
total
rna
ng
use
synthes
cdna
use
revoscript
rt
premix
intron
biotechnolog
sungnam
korea
qrtpcr
perform
use
primer
list
tabl
accupow
r
greenstar
qpcr
master
mix
bioneer
daejeon
korea
rel
express
calcul
use
ct
method
intern
refer
normal
mrna
express
level
choi
et
al
raw
cell
seed
onto
fourwel
tissu
cultur
slide
cultur
c
co
h
wef
quercetin
psoralen
ad
cell
cell
incub
c
co
h
medium
remov
cell
wash
cold
pb
raw
cell
incub
wef
lp
ngml
unit
c
co
h
cell
harvest
indic
time
h
protein
ripa
buffer
cell
lysat
separ
sdspage
transfer
polyvinyliden
difluorid
pvdf
membran
membran
block
bsa
h
incub
room
temperatur
h
primari
antibodi
dilut
antibodi
cell
signal
technolog
boston
usa
cell
signal
technolog
boston
usa
wash
blot
tb
three
time
hrpconjug
secondari
antibodi
dilut
incub
rt
h
protein
band
visual
use
chemiluminesc
reagent
thermo
scientif
waltham
usa
rel
intens
protein
band
measur
use
imag
j
fifteen
authent
standard
use
identif
phytochem
wef
psoralen
angelicin
rutin
quercitrin
isoquercitirin
syringin
caffeic
acid
acid
swerosid
scopoletin
intern
standard
purchas
chemfac
wuhan
china
quercetin
neochlorogen
acid
chlorogen
acid
pcoumar
acid
ferul
acid
oneway
anova
dunnett
test
use
comparison
two
group
treatment
effect
evalu
via
analysi
statist
analysi
perform
use
graphpad
prism
softwar
graphpad
prism
softwar
inc
version
ca
usa
p
p
p
indic
statist
signific
cytotox
wef
assess
use
mt
assay
h
treatment
murin
raw
macrophag
cell
variou
concentr
wef
wef
concentr
signific
cytotox
raw
cell
figur
therefor
subsequ
experi
investig
antivir
effect
perform
use
wef
concentr
proinflammatori
cytokin
type
interferon
play
signific
role
induc
antivir
respons
immunoregulatori
activ
theofilopoulo
et
al
perform
screen
test
identifi
proinflammatori
cytokin
observ
product
tradit
herbal
medicin
found
wef
relat
innat
immun
respons
induc
antivir
respons
product
cytokin
investig
effect
wef
secret
use
elisa
concentr
secret
pgml
respect
h
wef
treatment
figur
result
indic
mediat
antivir
respons
induc
wef
raw
cell
express
phosphoryl
nonphosphoryl
weftreat
raw
cell
determin
use
western
blot
analysi
result
indic
wef
treatment
upregul
phosphoryl
key
molecul
type
ifn
signal
pathway
figur
c
test
contamin
wef
endotoxin
lp
known
immunomodul
neg
accord
limulu
amebocyt
lysat
lal
assay
figur
investig
antivir
activ
wef
assess
suppress
viral
replic
use
gfpexpress
vsv
ndv
virus
raw
cell
viral
replic
monitor
via
gfp
express
weftreat
cell
exhibit
significantli
reduc
gfp
express
untreat
cell
high
level
gfp
express
upon
infect
vsv
figur
figur
ndv
figur
result
consist
viral
titer
gfpexpress
vsv
virus
cell
supernat
infect
cell
wef
treatment
significantli
reduc
viral
titer
nearli
gfpexpress
vsv
respect
hpi
figur
b
compar
untreat
cell
weftreat
cell
display
significantli
less
cell
death
follow
infect
test
virus
immunofluoresc
analysi
demonstr
weftreat
cell
express
significantli
less
protein
untreat
cell
hpi
figur
replic
gfpexpress
influenza
apuerto
viru
significantli
less
weftreat
cell
untreat
raw
cell
figur
thu
data
indic
wef
reduc
influenza
viral
protein
express
inhibit
identifi
composit
effect
bioactiv
compon
chemic
divers
complex
herbal
herbal
deriv
diversif
extract
raw
materi
product
method
avail
identifi
variou
compon
wef
studi
analyz
variou
tradit
use
water
extract
result
studi
uplcmsm
analysi
compar
retent
time
mass
fragment
authent
standard
identifi
follow
compon
wef
two
coumarin
psoralen
angelicin
four
flavonoid
rutin
quercitrin
isoquercitrin
quercetin
eight
phenol
neochlorogen
acid
chlorogen
acid
syringin
caffeic
acid
acid
pcoumar
acid
ocoumar
acid
ferul
acid
one
monoterpen
swerosid
figur
tabl
amount
identifi
phytochem
rang
mgg
extract
regard
antivir
effect
wef
rna
virus
may
result
benefici
effect
constitu
identifi
studi
first
test
antivir
activ
compon
wef
figur
express
pattern
influenza
viru
gene
ha
confirm
qrtpcr
subsequ
compon
treat
concentr
cell
harvest
rel
mrna
express
level
viral
gene
hpi
assess
qrtpcr
result
express
influenza
viru
ha
mrna
lower
untreat
cell
treatment
quercetin
psoralen
quercitrin
figur
next
investig
inhibit
influenza
viru
replic
function
express
raw
cell
use
gfpexpress
influenza
viru
gfp
express
significantli
reduc
cell
treat
frontier
pharmacolog
wwwfrontiersinorg
figur
induct
proinflammatori
cytokin
activ
type
ifn
wef
vitro
cell
treat
dmem
contain
fb
alon
unitml
recombin
mous
wef
incub
c
co
supernat
group
harvest
h
clarifi
centrifug
g
min
c
clarifi
supernat
dispens
murin
captur
antibodyco
elisa
plate
duplic
measur
cytokin
secret
b
c
western
blot
analysi
perform
whole
cell
lysat
macrophagetyp
cell
treat
without
wef
assess
express
nonphosphoryl
phosphoryl
form
time
similar
result
obtain
experi
perform
three
time
independ
detect
contamin
endotoxin
wef
limulu
amebocyt
lysat
lal
assay
eu
endotoxin
unit
p
p
vs
untreat
cell
quercetin
treat
psoralen
quercitrin
untreat
cell
figur
immunofluoresc
analysi
demonstr
express
protein
raw
cell
suppress
cell
treat
quercetin
treat
psoralen
untreat
cell
figur
investig
whether
quercetin
psoralen
quercitrin
treatment
inhibit
viral
mrna
np
pa
synthesi
cell
harvest
rel
mrna
express
level
viral
gene
hpi
assess
qrtpcr
synthesi
influenza
mrna
np
pa
dramat
suppress
quercetintr
cell
psoralenand
quercitrintr
cell
untreat
cell
figur
investig
effect
quercetin
psoralen
quercitrin
secret
measur
elisa
concentr
secret
h
treatment
quercetin
pgml
respect
figur
observ
total
wef
exert
strike
antivir
effect
cell
vitro
identifi
activ
compound
present
wef
use
uplcmsm
confirm
quercetin
psoralen
quercitrin
exhibit
antivir
effect
base
experiment
result
antivir
effect
immuneregulatori
properti
quercetin
investig
quercetin
psoralen
quercitrin
show
significantli
inhibit
viral
replic
induc
cytokin
secret
ifnbeta
thu
observ
antivir
activ
wef
may
exert
least
part
quercetin
psoralen
quercitrin
wef
role
immun
abil
human
bodi
defend
infecti
diseas
becom
import
frieman
et
al
new
infecti
diseas
avian
influenza
viru
middl
east
respiratori
syndrom
mer
acut
respiratori
syndrom
sar
infect
emerg
moren
fauci
occurr
viral
infect
mainli
occur
state
deterior
immun
function
variou
studi
conduct
find
natur
product
capabl
enhanc
immun
respons
matsumoto
et
al
wang
et
al
singh
et
al
choi
et
al
macrophag
play
role
rapidli
transmit
defens
mechan
viral
infect
macrophag
activ
inflammatori
reaction
produc
mani
cell
treat
wef
uml
influenza
viru
infect
influenza
viru
antibodi
use
detect
fluoresc
microscopi
cell
also
stain
dapi
merg
imag
show
cytoplasm
locat
viru
protein
red
b
raw
cell
treat
wef
uml
h
infect
moi
antivir
effect
verifi
h
viral
infect
presenc
absenc
gfp
express
inflammatori
factor
includ
tumor
necrosi
ellermanneriksen
theofilopoulo
et
al
melchjorsen
et
al
proinflammatori
cytokin
type
interferon
play
import
role
induc
antivir
respons
immunoregulatori
activ
konopka
et
al
paludan
et
al
continu
induc
synthesi
antivir
protein
inhibit
intracellular
viral
replic
promot
adapt
immun
virus
yoneyama
et
al
studi
sought
elucid
mechan
underli
wef
antivir
activ
observ
wef
treatment
induc
high
level
secret
figur
compar
untreat
cell
h
wefinduc
may
mediat
antivir
state
raw
cell
also
observ
wef
treatment
induc
increas
phosphoryl
rel
untreat
cell
h
figur
observ
wef
protect
raw
cell
infect
rna
virus
vsv
ndv
influenza
antivir
activ
monitor
decreas
gfp
express
cell
expos
gfplabel
virus
weftreat
cell
exhibit
markedli
lower
gfp
express
untreat
cell
express
high
level
gfp
rna
virus
vsv
ndv
figur
result
consist
titer
vsv
ndv
supernat
infect
cell
wef
treatment
decreas
titer
vsv
nearli
respect
figur
b
result
clearli
indic
wef
inhibit
replic
rna
virus
raw
cell
underli
mechan
wef
antivir
activ
like
involv
induct
type
ifn
proinflammatori
cytokin
secret
wef
compon
includ
quercetin
psoralen
quercitrin
lead
antivir
state
host
cell
wef
thu
promis
prophylact
agent
inhibit
viral
infect
activ
innat
immun
sever
limit
studi
acknowledg
optim
dosag
wef
practic
applic
durat
effect
within
host
examin
obtain
best
possibl
protect
viral
infect
addit
studi
investig
antivir
activ
wef
compon
vitro
therefor
extens
studi
need
assess
potenti
wef
compon
use
vivo
antivir
therapi
addit
studi
determin
specif
signal
pathway
involv
wef
action
role
interact
wef
compon
antivir
activ
also
need
genu
eupatorium
famili
asteracea
known
includ
speci
world
includ
asia
america
africa
europ
known
mani
biolog
activ
includ
antinocicept
antiinflammatori
antibacteri
antifung
anticanc
antiplasmodi
antioxid
antiallerg
activ
immunomodul
properti
chemic
composit
eupatorium
speci
includ
bioactiv
compound
flavonoid
monoterpen
deriv
sesquiterpen
diterpen
triterpen
pyrrolizidin
alkaloid
essenti
oil
compon
addit
extract
eupatorium
speci
compon
report
exhibit
antivir
effect
exampl
euparin
isol
e
chinens
exhibit
quercitrin
isoquercitirin
quercetin
neochlorogen
acid
chlorogen
acid
syringin
caffeic
acid
acid
pcoumar
acid
ferul
acid
ocoumar
acid
swerosid
antivir
activ
respiratori
syncyti
viru
wang
et
al
hydroalcohol
extract
e
perfoliatum
exhibit
antivir
activ
influenza
viru
mediat
interact
viral
hemagglutinin
derksen
et
al
e
adenophorum
polysaccharid
confer
protect
effect
influenza
infect
jin
et
al
euparin
e
buniifolium
exhibit
antivir
activ
polioviru
type
visintini
jaim
et
al
pseudorabi
viru
strain
zanon
et
al
essenti
oil
e
paten
inactiv
garcia
et
al
furthermor
extract
e
buniifolium
e
articulatum
exhibit
antivir
effect
vsv
respect
e
glutinosum
inhibit
vsv
replic
abad
et
al
studi
wef
compon
analysi
activ
test
show
quercetin
excel
antivir
effect
influenza
viru
report
quercetin
compon
present
e
odoratum
yuan
et
al
e
lindleyanum
qian
et
al
e
ballotaefolium
militao
et
al
plant
may
antivir
efficaci
also
accord
recent
research
result
quercetin
shown
protect
entri
influenza
viru
wu
et
al
interact
human
respiratori
syncyti
viru
protein
teixeira
et
al
properti
lee
et
al
inhibit
coronaviru
dengu
viru
infect
chiow
et
al
thu
e
odoratum
e
lindleyanum
e
ballotaefolium
possibl
antivir
effect
variou
rna
virus
cell
treat
dmem
contain
fb
alon
uml
recombin
mous
ugml
quercetin
psoralen
quercitrin
supernat
group
harvest
h
clarifi
dispens
murin
captur
antibodyco
elisa
plate
measur
cytokin
secret
ns
signific
p
p
vs
untreat
cell
conclus
studi
first
demonstr
efficaci
wef
altern
antivir
agent
wef
inhibit
vsv
ndv
replic
murin
macrophag
via
induct
proinflammatori
cytokin
type
ifn
signal
lead
antivir
state
wef
compon
includ
quercetin
psoralen
quercitrin
use
therapeut
prevent
agent
limit
viral
replic
furthermor
wef
compon
may
use
start
materi
develop
potent
herbal
agent
select
viral
infect
